Home > > > > Report Detail

Global Companion Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 08-Nov-2022
No. of pages: 113
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Companion Diagnostic companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Companion Diagnostic market. Further, it explains the major drivers and regional dynamics of the global Companion Diagnostic market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Roche Holdings

- Abbott Laboratories

- Thermo Fisher Scientific

- Agilent Technologies

- Merck

- Agendia

- Qiagen

- Myriad Genetics

- Advanced Cell Diagnostics

- Danaher

- Illumina, Inc

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Companion Diagnostic Segment by Type

- Immunohistochemistry

- Molecular Diagnosis

Companion Diagnostic Segment by Application

- Oncology

- Cardiovascular

- Central Nervous System

- Virology

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Companion Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Companion Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Companion Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Companion Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Companion Diagnostic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Companion Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Companion Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics and Advanced Cell Diagnostics, etc.

Global Companion Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnosis
1.3 Market by Application
1.3.1 Global Companion Diagnostic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Virology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Companion Diagnostic Market Size (2017-2028)
2.2 Companion Diagnostic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Companion Diagnostic Market Size by Region (2017-2022)
2.4 Global Companion Diagnostic Market Size Forecast by Region (2023-2028)
2.5 Global Top Companion Diagnostic Countries Ranking by Market Size
3 Companion Diagnostic Competitive by Company
3.1 Global Companion Diagnostic Revenue by Players
3.1.1 Global Companion Diagnostic Revenue by Players (2017-2022)
3.1.2 Global Companion Diagnostic Market Share by Players (2017-2022)
3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Companion Diagnostic Revenue
3.4 Global Companion Diagnostic Market Concentration Ratio
3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2021
3.5 Global Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Companion Diagnostic Breakdown Data by Type
4.1 Global Companion Diagnostic Historic Revenue by Type (2017-2022)
4.2 Global Companion Diagnostic Forecasted Revenue by Type (2023-2028)
5 Global Companion Diagnostic Breakdown Data by Application
5.1 Global Companion Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Companion Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Diagnostic Revenue by Company (2020-2022)
6.2 North America Companion Diagnostic Revenue by Type (2017-2028)
6.3 North America Companion Diagnostic Revenue by Application (2017-2028)
6.4 North America Companion Diagnostic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Companion Diagnostic Revenue by Company (2020-2022)
7.2 Europe Companion Diagnostic Revenue by Type (2017-2028)
7.3 Europe Companion Diagnostic Revenue by Application (2017-2028)
7.4 Europe Companion Diagnostic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Companion Diagnostic Revenue by Company (2020-2022)
8.2 Asia Pacific Companion Diagnostic Revenue by Type (2017-2028)
8.3 Asia Pacific Companion Diagnostic Revenue by Application (2017-2028)
8.4 Asia Pacific Companion Diagnostic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Companion Diagnostic Revenue by Company (2020-2022)
9.2 Latin America Companion Diagnostic Revenue by Type (2017-2028)
9.3 Latin America Companion Diagnostic Revenue by Application (2017-2028)
9.4 Latin America Companion Diagnostic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Companion Diagnostic Revenue by Company (2020-2022)
10.2 Middle East and Africa Companion Diagnostic Revenue by Type (2017-2028)
10.3 Middle East and Africa Companion Diagnostic Revenue by Application (2017-2028)
10.4 Middle East and Africa Companion Diagnostic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Details
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostic Products and Services
11.1.4 Roche Holdings Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.1.5 Roche Holdings Companion Diagnostic SWOT Analysis
11.1.6 Roche Holdings Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostic Products and Services
11.2.4 Abbott Laboratories Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.2.5 Abbott Laboratories Companion Diagnostic SWOT Analysis
11.2.6 Abbott Laboratories Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostic Products and Services
11.3.4 Thermo Fisher Scientific Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.3.5 Thermo Fisher Scientific Companion Diagnostic SWOT Analysis
11.3.6 Thermo Fisher Scientific Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostic Products and Services
11.4.4 Agilent Technologies Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.4.5 Agilent Technologies Companion Diagnostic SWOT Analysis
11.4.6 Agilent Technologies Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Companion Diagnostic Products and Services
11.5.4 Merck Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.5.5 Merck Companion Diagnostic SWOT Analysis
11.5.6 Merck Recent Developments
11.6 Agendia
11.6.1 Agendia Company Details
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Products and Services
11.6.4 Agendia Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.6.5 Agendia Companion Diagnostic SWOT Analysis
11.6.6 Agendia Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Companion Diagnostic Products and Services
11.7.4 Qiagen Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.7.5 Qiagen Companion Diagnostic SWOT Analysis
11.7.6 Qiagen Recent Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Details
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Companion Diagnostic Products and Services
11.8.4 Myriad Genetics Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.8.5 Myriad Genetics Companion Diagnostic SWOT Analysis
11.8.6 Myriad Genetics Recent Developments
11.9 Advanced Cell Diagnostics
11.9.1 Advanced Cell Diagnostics Company Details
11.9.2 Advanced Cell Diagnostics Business Overview
11.9.3 Advanced Cell Diagnostics Companion Diagnostic Products and Services
11.9.4 Advanced Cell Diagnostics Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.9.5 Advanced Cell Diagnostics Companion Diagnostic SWOT Analysis
11.9.6 Advanced Cell Diagnostics Recent Developments
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Products and Services
11.10.4 Danaher Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.10.5 Danaher Companion Diagnostic SWOT Analysis
11.10.6 Danaher Recent Developments
11.11 Illumina, Inc
11.11.1 Illumina, Inc Company Details
11.11.2 Illumina, Inc Business Overview
11.11.3 Illumina, Inc Companion Diagnostic Products and Services
11.11.4 Illumina, Inc Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022)
11.11.5 Illumina, Inc Recent Developments
12 Companion Diagnostic Market Dynamics
12.1 Companion Diagnostic Market Trends
12.2 Companion Diagnostic Market Drivers
12.3 Companion Diagnostic Market Challenges
12.4 Companion Diagnostic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Immunohistochemistry
Table 3. Key Players of Molecular Diagnosis
Table 4. Global Companion Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Companion Diagnostic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Companion Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Companion Diagnostic Revenue Market Share by Region (2017-2022)
Table 8. Global Companion Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Companion Diagnostic Market Share by Players (2017-2022)
Table 10. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
Table 11. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Companion Diagnostic Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Companion Diagnostic Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Companion Diagnostic Revenue Market Share by Type (2017-2022)
Table 19. Global Companion Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Companion Diagnostic Revenue Market Share by Type (2023-2028)
Table 21. Global Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Companion Diagnostic Revenue Market Share by Application (2017-2022)
Table 23. Global Companion Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Companion Diagnostic Revenue Market Share by Application (2023-2028)
Table 25. North America Companion Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Companion Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Companion Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Companion Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Companion Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Companion Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Companion Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Companion Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Companion Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Companion Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Companion Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Companion Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Companion Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Companion Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Companion Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Companion Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Companion Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Companion Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Companion Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Companion Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Companion Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Companion Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Companion Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Companion Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Companion Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Companion Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Companion Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Companion Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Companion Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Companion Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Companion Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Companion Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Companion Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Companion Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Companion Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 60. Roche Holdings Company Details
Table 61. Roche Holdings Business Overview
Table 62. Roche Holdings Companion Diagnostic Product and Services
Table 63. Roche Holdings Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 64. Roche Holdings Companion Diagnostic SWOT Analysis
Table 65. Roche Holdings Recent Developments
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Companion Diagnostic Product and Services
Table 69. Abbott Laboratories Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 70. Abbott Laboratories Companion Diagnostic SWOT Analysis
Table 71. Abbott Laboratories Recent Developments
Table 72. Thermo Fisher Scientific Company Details
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Companion Diagnostic Product and Services
Table 75. Thermo Fisher Scientific Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 76. Thermo Fisher Scientific Companion Diagnostic SWOT Analysis
Table 77. Thermo Fisher Scientific Recent Developments
Table 78. Agilent Technologies Company Details
Table 79. Agilent Technologies Business Overview
Table 80. Agilent Technologies Companion Diagnostic Product and Services
Table 81. Agilent Technologies Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 82. Agilent Technologies Companion Diagnostic SWOT Analysis
Table 83. Agilent Technologies Recent Developments
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Companion Diagnostic Product and Services
Table 87. Merck Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 88. Merck Companion Diagnostic SWOT Analysis
Table 89. Merck Recent Developments
Table 90. Agendia Company Details
Table 91. Agendia Business Overview
Table 92. Agendia Companion Diagnostic Product and Services
Table 93. Agendia Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 94. Agendia Companion Diagnostic SWOT Analysis
Table 95. Agendia Recent Developments
Table 96. Qiagen Company Details
Table 97. Qiagen Business Overview
Table 98. Qiagen Companion Diagnostic Product and Services
Table 99. Qiagen Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 100. Qiagen Companion Diagnostic SWOT Analysis
Table 101. Qiagen Recent Developments
Table 102. Myriad Genetics Company Details
Table 103. Myriad Genetics Business Overview
Table 104. Myriad Genetics Companion Diagnostic Product and Services
Table 105. Myriad Genetics Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 106. Myriad Genetics Companion Diagnostic SWOT Analysis
Table 107. Myriad Genetics Recent Developments
Table 108. Advanced Cell Diagnostics Company Details
Table 109. Advanced Cell Diagnostics Business Overview
Table 110. Advanced Cell Diagnostics Companion Diagnostic Product and Services
Table 111. Advanced Cell Diagnostics Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 112. Advanced Cell Diagnostics Companion Diagnostic SWOT Analysis
Table 113. Advanced Cell Diagnostics Recent Developments
Table 114. Danaher Company Details
Table 115. Danaher Business Overview
Table 116. Danaher Companion Diagnostic Product and Services
Table 117. Danaher Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 118. Danaher Companion Diagnostic SWOT Analysis
Table 119. Danaher Recent Developments
Table 120. Illumina, Inc Company Details
Table 121. Illumina, Inc Business Overview
Table 122. Illumina, Inc Companion Diagnostic Product and Services
Table 123. Illumina, Inc Companion Diagnostic Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 124. Illumina, Inc Recent Developments
Table 125. Companion Diagnostic Market Trends
Table 126. Companion Diagnostic Market Drivers
Table 127. Companion Diagnostic Market Challenges
Table 128. Companion Diagnostic Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Sales Market Share by Type: 2021 VS 2028
Figure 2. Immunohistochemistry Features
Figure 3. Molecular Diagnosis Features
Figure 4. Global Companion Diagnostic Sales Market Share by Application: 2021 VS 2028
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Case Studies
Figure 7. Central Nervous System Case Studies
Figure 8. Virology Case Studies
Figure 9. Others Case Studies
Figure 10. Companion Diagnostic Report Years Considered
Figure 11. Global Companion Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Companion Diagnostic Market Size 2017-2028 (US$ Million)
Figure 13. Global Companion Diagnostic Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Companion Diagnostic Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Companion Diagnostic Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Companion Diagnostic Market Share by Players in 2021
Figure 17. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2021
Figure 19. North America Companion Diagnostic Revenue Market Share by Company in 2021
Figure 20. North America Companion Diagnostic Revenue Market Share by Type (2017-2028)
Figure 21. North America Companion Diagnostic Revenue Market Share by Application (2017-2028)
Figure 22. North America Companion Diagnostic Revenue Share by Country (2017-2028)
Figure 23. U.S. Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Companion Diagnostic Revenue Market Share by Company in 2021
Figure 26. Europe Companion Diagnostic Revenue Market Share by Type (2017-2028)
Figure 27. Europe Companion Diagnostic Revenue Market Share by Application (2017-2028)
Figure 28. Europe Companion Diagnostic Revenue Share by Country (2017-2028)
Figure 29. Germany Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 30. France Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Companion Diagnostic Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Companion Diagnostic Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Companion Diagnostic Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Companion Diagnostic Revenue Share by Region (2017-2028)
Figure 38. China Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 41. India Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America Companion Diagnostic Revenue Market Share by Company in 2021
Figure 50. Latin America Companion Diagnostic Revenue Market Share by Type (2017-2028)
Figure 51. Latin America Companion Diagnostic Revenue Market Share by Application (2017-2028)
Figure 52. Latin America Companion Diagnostic Revenue Share by Country (2017-2028)
Figure 53. Mexico Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Companion Diagnostic Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa Companion Diagnostic Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Companion Diagnostic Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Companion Diagnostic Revenue Share by Country (2017-2028)
Figure 60. Turkey Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 62. U.A.E Companion Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 63. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 64. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 66. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 67. Merck Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 68. Agendia Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 69. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 70. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 71. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 72. Danaher Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 73. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
  • Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
    Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309
    “Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......
  • Global Pharmaceutical Testing Services Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102
    Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......
  • Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......
  • Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......
  • Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......
  • Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......
  • Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151
    According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......
  • Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......
  • IVD Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs